Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Poster No. 49 Title: Novel 3D Tissue Models of Human Cancer: Identification of Therapeutic Targets in Translational Drug Discovery and Development Authors: Jonathan Garlick, Addy Alt-Holland, Yulia Shamis, Teresa DesRochers, Denis Arnaud, Katie Riley, Christophe Egles, Ira Herman Presented by: Jonathan Garlick Department(s): Division of Cancer Biology and Tissue Engineering, Department of Oral and Maxillofacial Pathology, Tufts University School of Dental Medicine Abstract: The construction of human 3D tissue models of stratified squamous epithelium provides unique experimental paradigms that can trace the complex interplay between multiple cell and tissue types in a biologicallymeaningful context. These tissues provide a more global picture of how disease-associated pathways interact in an environment that mimics malignant human tissues and serve as “surrogate” tissues that have set the stage for the accelerated translation of discoveries to the clinic through strategies that will allow target identification and validation. We have developed 3D tissue biology as a portal to translational discovery of pathways linked to human squamous cell carcinoma (SCC) progression and that now serve as paradigms for the discovery and development of cancer therapeutics. These 3D human tissues mimic distinct stages of squamous cell carcinoma in humans including: 1) precancer, 2) low-grade carcinoma, and 3) high-grade carcinoma. We have accomplished this by constructing tissues at an air-liquid interface in which cells have been genetically-modified by suppressing expression of E-cadherin. In light of the emerging view that cancer is a disease of altered tissue architecture driven by abnormal interactions between tumor cells and their tissue microenvironment, we have defined 4 distinct microenvironments that a potentially-malignant SCC cell must encounter as it evolves from precancer to malignancy: 1) intraepithelial dormancy, 2) transepithelial migration through the epithelial layers, 3) attachment and degradation of the basement membrane interface, and 4) migration through collagenous stroma. By viewing each of these unique microenvironments as a drug-therapy target, these 3D models have tremendous potential by extending observations gleaned from rudimentary cell culture to the patient-care setting. 51